Font Size:
a
A
A
Keyword [Relapsed/Refractory Diffuse Large B-cell Lymphoma]
Result: 1 - 8 | Page: 1 of 1
1.
The Separation Of Specific Serum Protein Biomarker In Patients With Relapse/refractory Diffuse Large B Cell Lymphoma And The Study Of Its Clinical Value
2.
Predictive Value Of Serum Amyloid A And Misfolded Transthyretin In Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
3.
Clinical Characteristics And Prognosis Prediction Model For Patients With Relapsed/refractory Diffuse Large B-cell Lymphoma
4.
The Clinical Observation Of The Modified BACOD Regimen Combined With Recombinant Mutated Human Tumor Necrosis Factor For Relapsed/refractory Diffuse Large B-cell Lymphoma
5.
Analysis Of The Efficacy,Side Effects And Prognostic Factors Of DA-EPOCH±R Regimen And Modified ESHAP±R Regimen For Relapsed/Refractory Diffuse Large B-cell Lymphoma
6.
CAR19-T Cells Secreting IL-21 And PD1-Fc For The Treatment Of Relapsed/refractory Diffuse Large B Cell Lymphoma
7.
Clinical Efficacy And Safety Analysis Of Apatinib In The Treatment Of Relapsed And Refractory Diffuse Large B-cell Lymphoma
8.
Safety And Efficacy Of Anti-PD-1/PD-l1 Antibodies In Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma:a Meta-Analysis
<<First
<Prev Next>
Last>>
Jump to